Technology News and Research

RSS

Project aims to find new diagnostic tools, drugs for triple negative breast cancer

Some types of breast cancer can be successfully treated with drugs such as tamoxifen, but treatment for a type of breast cancer more common in young and black women is still limited to radiation and general chemotherapy. Called triple negative breast cancer, this type of cancer is the focus of a 20-month, $8.6-million research project that aims to find new diagnostic tools and options for drugs.

17 May 2012

La. panel kills health exchange plan; Kansas enacts another abortion hurdle; Utah official resigns after medical records breach

With a decisive 8-1 vote late Tuesday evening, the Louisiana Senate Finance Committee buried a bill that would have set up a body of elected and appointed officials to craft the exchanges that are an anchor of President Barack Obama's health insurance overhaul. With the death of Senate Bill 744, Louisiana remains one of a handful of states that have refused to set up their own exchanges, with Gov. Bobby Jindal punting the job back to federal government that he accuses of taking over the American health care system

17 May 2012

TRCARC, IBM partner to strengthen HIV prevention effort

IBM is collaborating with the Thai Red Cross AIDS Research Center (TRCARC) to strengthen HIV prevention effort and to make Bangkok the world's first city to achieve "Zero New HIV Infections" by 2015.

17 May 2012

Zyga Technology raises $25 million in Series C financing

Zyga Technology announced today that it had raised $25 million in a Series C financing led by new investor Versant Ventures of Menlo Park, California. Joining Versant in this round are existing investors Split Rock Partners, Domain Associates, and MB Venture Partners. With this investment, Kirk Nielsen, Managing Director, Versant Ventures will join the board of directors of Zyga.

17 May 2012

Pfizer outlines vision for Systems-based Pharmaceutics

Leading pharmaceuticals company Pfizer outlined its vision for Systems-based Pharmaceutics, a revolutionary model-based approach linking drug process and product engineering to product quality and performance in the human body, at the recent Advanced Process Modelling Forum in London.

17 May 2012

NanoString commences second clinical study of PAM50-based breast cancer assay

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay.

From NanoString Technologies 17 May 2012

CryoLife acquires Hemosphere

CryoLife, Inc., a leading medical device company focused on cardiac and vascular surgery, announced today that it has completed its previously announced acquisition of Hemosphere, Inc.

17 May 2012

NeuroSigma Subsidiary sees potential for Thin-Film Nitinol in next-generation flow-diverting stents for treating intracranial aneurysms

NeuroSigma, Inc., a Los Angeles-based medical device company, today announced that its majority-owned subsidiary, NSVascular, Inc. (NSV), acquired a portfolio of patents and related trade secrets covering the fabrication of Thin-Film Nitinol (TFN) from TiNi Alloy Company, including U.S. Patent No. 6,746,890 entitled “Three Dimensional Thin Film Devices and Methods of Fabrication,” an important piece of the portfolio covering the production of three-dimensional TFN constructs.

16 May 2012

Hitting the target: IntelliCap provides reliable and accurate regional drug delivery

Medimetrics, recently certified to ISO 13485, has successfully developed the IntelliCap system, specifically designed to target delivery of small molecule drugs and biologics to the gastrointestinal (GI) tract. The technology is capable of achieving controlled release of drugs to specific GI sites in a fast, cost-effective and convenient manner (Shimizu et al., 2008).

16 May 2012

Treatment in hospitals with medical fellowships improves outcome for prostate cancer radical surgery

Patients who undergo radical surgery for prostate cancer may expect better results, on average, if they're treated in accredited teaching hospitals with residency programs, and better still if the hospitals also have medical fellowships, according to a new study by Henry Ford Hospital.

16 May 2012

PN kidney cancer surgery not being used for older, sicker and poorer uninsured patients

An increasingly common and safer type of surgery for kidney cancer is not as likely to be used for older, sicker and poorer patients who are uninsured or rely on Medicare or Medicaid for their health care, according to a new study by researchers at Henry Ford Hospital.

16 May 2012

Ultrasensitive biosensor may open up new opportunities for early detection of cancer

Researchers have created an ultrasensitive biosensor that could open up new opportunities for early detection of cancer and "personalized medicine" tailored to the specific biochemistry of individual patients.

16 May 2012

CINJ prefers more personalized approach to prescribing cancer treatment

With recent advancements in technology and biomedical informatics, a more personalized approach to prescribing cancer treatment and developing these therapies is preferred over "one-size-fits-all" methods.

16 May 2012

First Edition: May 16, 2012

Today's headlines highlight the growing partisan faultlines regarding budget issues, including spending cuts and entitlement reforms.

16 May 2012

First patient included in the phase II study of Amphinex® in head and neck cancer patients

PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that the first patient has been included in the phase II study of Amphinex in combination with the cytotoxic agent bleomycin in head and neck cancer patients, called the ENHANCE study. The first patient was included at the National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany. NCT is a joint project of the German Cancer Research Center (DKFZ), Heidelberg University Hospital, Thoraxklinik Heidelberg and Deutsche Krebshilfe (German Cancer Aid).

16 May 2012

Quality Systems announces acquisition of The Poseidon Group

Quality Systems, Inc., announced today the acquisition of The Poseidon Group, Inc. to support the growth of its NextGen Inpatient Solutions offering, which provides a range of healthcare information technology services to small hospitals.

16 May 2012

Age-adjusted melanoma on the rise

As the U.S. observes Skin Cancer Awareness Month in May, a report published in the April issue of Mayo Clinic Proceedings has some sobering news for young adults: The incidence of melanoma increased eightfold among young women and fourfold among young men from 1970 through 2009.

16 May 2012

Sorin receives PMDA authorization to market MEMO 3D ring

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announces that it received authorization from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) to market its MEMO 3D Semi-Rigid Annuloplasty Ring.

16 May 2012

With limited budget, prioritizing investments in projects to advance human welfare is critical

"If you had $75 billion to spend over the next four years and your goal was to advance human welfare, especially in the developing world, how could you get the most value for your money?" Bjorn Lomborg, an author and director of the Copenhagen Consensus Center, asks in this opinion piece in Slate Magazine's "Copenhagen Consensus 2012" section.

16 May 2012

Avita commences enrollment in ReCell study for hypertrophic dyspigmented scars

Avita Medical Ltd.,the regenerative medicine company, today announced that it has commenced enrolment in the US FDA-approved feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars.

16 May 2012

Technology News and Research

Project aims to find new diagnostic tools, drugs for triple negative breast cancer

La. panel kills health exchange plan; Kansas enacts another abortion hurdle; Utah official resigns after medical records breach

TRCARC, IBM partner to strengthen HIV prevention effort

Zyga Technology raises $25 million in Series C financing

Pfizer outlines vision for Systems-based Pharmaceutics

NanoString commences second clinical study of PAM50-based breast cancer assay

CryoLife acquires Hemosphere

NeuroSigma Subsidiary sees potential for Thin-Film Nitinol in next-generation flow-diverting stents for treating intracranial aneurysms

Hitting the target: IntelliCap provides reliable and accurate regional drug delivery

Treatment in hospitals with medical fellowships improves outcome for prostate cancer radical surgery

PN kidney cancer surgery not being used for older, sicker and poorer uninsured patients

Ultrasensitive biosensor may open up new opportunities for early detection of cancer

CINJ prefers more personalized approach to prescribing cancer treatment

First Edition: May 16, 2012

First patient included in the phase II study of Amphinex® in head and neck cancer patients

Quality Systems announces acquisition of The Poseidon Group

Age-adjusted melanoma on the rise

Sorin receives PMDA authorization to market MEMO 3D ring

With limited budget, prioritizing investments in projects to advance human welfare is critical

Avita commences enrollment in ReCell study for hypertrophic dyspigmented scars

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News